Multi-omic single cell sequencing: Overview and opportunities for kidney disease therapeutic development

Steven Pregizer1, Thom Vreven1, Mohit Mathur1

  • 1Visterra Inc., Waltham, MA, United States.

Summary

Single cell multi-omic sequencing provides deep biological insights by analyzing gene expression, chromatin accessibility, and protein levels. This technology offers new avenues for developing kidney disease therapeutics through biomarker discovery and patient stratification.